References
Ning, Y. et al., (2009) Atherosclerosis 204:114–120. 1. Murthy, S., et al., J. Lipid Res. 43: 1054-1064 (2002). 2. Burgess, J.W., et al., JBC Papers in Press. 277(35): 31,318-31,326 (2002). 3. Haidar, B., et al., J. Lipid Res. 43(12): 2087-2094 (2002). 4. Terasaka, N., et al., FEBS Letters. 536: 6-11 (2003). 5. Basso, F., et al., J. Lipid Res. 44: 296-302 (2003). 6. Le Lay, S., et al., J. Lipid Res. 44(8): 1499-1507 (2003). 7. Khovidhunkit, W., et al., J. Lipid Res. 44: 1728-1736 (2003). 8. Han, J., et al., JBC Papers in Press. 276(19): 16,567-16,572 (2001). 9. Wang, N., et al., J. Clin. Invest.111(1): 99-107 (2003). 10. Escher, G., et al. J. Biol. Chem. 278(13): 11,015-11,019 (2003). 11. Feng, B., et al., J. Biol. Chem. 277(45): 43,271-43,280 (2002). 12. Fukumoto, H., et al., J. Biol. Chem. 277(50): 48,508-48,513 (2002). 13. Koldamova, R., et al., J. Biol. Chem. 278(15): 13,244-13,256 (2003). 14. Sun, Y., et al., J. Biol. Chem. 278(30): 27,688-27,694 (2003). 15. Witting, S., et al., J. Biol. Chem. 278(41): 40,121-40,127 (2003). 16. Krimbou, et al., J. Biol. Chem. 45: 839-848 (2004). 17. Denis, M., et al., J. Biol. Chem. 279(9): 7384-7394 (2004). 18. Krimbou, L., et al., J. Lipid Res. 45: 839-848 (2004). 19. Denis, M., et al., J. Biol. Chem. 279(40): 41,529-41,536 (2004). 20. Koldamova, R., et al., J. Biol. Chem. 280(6): 4079-4088 (2005). 17. Gaus, K., et al. PNAS. 100(26): 15554-15559, 2003. (human) 18. Denis, M., et al. Journal of Biological Chemistry. 279(9):7384-7394,2004. 19. Bortnick, A: Am J Physiol Lung Cell Mol Physiol 285: L869-L878, 2003. 20. Wagner, B: Promoter-Specific Roles for Liver X Receptor/Corepressor Complexes in the Regulation of ABCA1 and SREBP1 Gene Expression. Molecular And Cellular Biology, Aug.2003, pp. 5780-5789. 21. Sun, Y: Expression of Liver X Receptor Target Genes Decreases Cellular Amyloid beta Peptide Secretion. The Journal of Biological Chemistry. Vol.278, No.30 July 25,pp. 27688-27694, 2003. 22. Field, F., et al. LXR/RXR ligand activation enhances basolateral efflux of beta-sitosterol in CaCo-2 cells. Journal of Lipid Research. 45:905-913, 2004. 23. Krimbou, L., et al. Molecular interactions between apoE and ABCA1: impact on apoE lipidation. Journal of Lipid Research. 45:839-848, 2004. 24. Brown III, J., et al. Differential Expression of Cholesterol Hydroxylase in Alzheimer’s Disease. The Journal of Biological Chemistry. 279(33):34674-34681, 2004. 25. Sahoo, D., et al. ABCA1-dependent lipid effulux to apolipoprotein A-1 mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes. Journal of Lipid Research. 45: 1122-1131, 2004 26. Denis, M., et al. Characterization of Oligomeric Human ATP Binding Cassette Transporter A1. The Journal of Biological Chemistry. 279(40):41529-41536, 2004. 27. Fitzgerald, M., et al. ATP-binding Cassette Transporter A1 Contains an NH(2)-terminal Signal Anchor Sequence That Translocates the Protein's First Hydrophilic Domain to the Exoplasmic Space. 276(18): 15137-15145, 2001. 28. Gaus, K., et al. Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. The FASEB Journal. 10.1096/fr.03-0486fje., 2004. 29. Koldamova, R., et al. The Liver Receptor Ligand T0901317 Decreases Amyloid Beta Production in Vitro and in a Mouse Model of Alzheimer's Disease. The Journal of Biological Chemistry. 280(6): 4079-4088, 2005. 30. Ando, H., et al. Effects of Pravastatin on the Expression of ATP-Binding Cassette Transporter A1. J. Pharmacol. Exp. Ther. 311: 420-425, 2004. 31. Li. A., et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPAR alpha alpha, B/delta, and gamma. J. Clin. Invest. 114: 1564-1576, 2004. 32. Haidar, B., et al. Apolipoprotein A-I Activates Cellular cAMP Signaling through the ABCA1 Transporter. J. Biol. Chem. 279: 9963-9969, 2004. 33. Bared, S., et al. Association of ABCA1 with Syntaxin 13 and Flotillin-1 and Enhanced Phagocytosis in Tangier Cells. Mol. Biol. Cell. 15: 5399-5407, 2004. 34. Koldamova, R., et al. The LXR ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J. Biol. Chem. 10.1074/jbc.M411420200, 2004. 35. Dove, D. ACAT1 Deficiency Disrupts Cholesterol Efflux and Alters Cellular Morphology in Macrophages. Arterioscler. Thromb. Vasc. Biol. 25: 128-134, 2004. 36. Agassandian, M., et al. Oxysterols Trigger ABCA1-Mediated Basolateral Surfactant Efflux. Am. J. Respir. Cell Mol. Biol. 31: 227-233, 2004. 37. O'Connell, B., et al. Cellular Physiology of Cholesterol Efflux in Vascular Endothelial cells. Circulation. 110: 2881-2888, 2004. 38. Zeng, L., et al. Sterol-responsive Element-binding Protein (SREBP) 2 Down-regulates ATP-binding Cassette Transporter A1 in Vascular Endothelial Cells: A NOVEL ROLE OF SREBP IN REGULATING CHOLESTEROL METABOLISM. J. Biol. Chem. 279: 48801-48807, 2004.1. Orso, E., et al. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat. Genet. 24(2): 192-196, 2000. 2. Chen, W. et al. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages. J. Biol. Chem. 275(40): 30794-30800. 20003. 3. Wang, N., et al. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABCA1. J. Biol. Chem. 275(42): 33053-58, 2000 4. Su, Y., et al. Macrophage Apolipoprotein A-I Expression Protects against Atherosclerosis in ApoE-Deficient Mice and Up-regulates ABC Transporters. Molecular Therapy. 0:1-8,2003 5. Schmid, K., et al. Transport of cholesterol across a BeWo cell monolayer: implications for net transport of sterol from maternal to fetal circulation. Journal of Lipid Research. 44: 1909-1918, 2003. 6. Khovidhunkit, W. et al. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: defferential role of LXR. Journal of Lipid Research. 44: 1728-1736, 2003.USBio References
US Biological application reference: Ning, Y. et al., (2009) Atherosclerosis 204:114–120.